Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox Biochip Array Technology is the Leading Methodology for Drug Detection in Oral Fluid

Published: Tuesday, December 27, 2011
Last Updated: Tuesday, December 27, 2011
Bookmark and Share
Offers a diagnostic grade testing solution with reliable and reproducible results.

Testing of oral fluid specimens is becoming increasingly popular in the workplace, prisons and in drug rehabilitation clinics. Its usefulness as an aid in clinical diagnosis has been acknowledged and as a result there are many testing devices on the market for oral fluid screening.

Unlike rapid tests, Randox Biochip Array Technology offers a diagnostic grade testing solution with reliable and reproducible results.

Biochip arrays offer a one-shot multiplex assay, detecting up to ninety-seven drugs and drug metabolites from an undivided oral fluid sample.

Matrix dedicated kits ensure leading assay performance and excellent specificity, even at lower drug concentrations.

Randox biochip arrays meet the limit of detection requirements for both the European Workplace Drug Testing Society guidelines for oral fluid testing (2010) and the Australian and New Zealand procedures for specimen collection and the detection and quantification of drugs in oral fluid AS 4760-2006 (2006).

The highly efficient Biochip arrays also provide a rapid turn around time, which is advantageous for onsite workplace drug testing. In comparison, a four-plate automated ELISA system would require thirteen times longer to process the same results.

Randox recently launched a point of collection biochip analyzer; the ‘Evidence MultiStat’ which processes multiple results in less than twenty minutes.

The Biochip platform is multi-matrix, therefore a number of sample types including oral fluid, whole blood, urine and post-mortem tissue can be run on the system.

The Randox line of Evidence immunoassay analyzers generate quality control data automatically with every run, ensuring that each test has been carried out successfully.

With a number of benefits to be gained from onsite testing, oral fluid will continue to be put into practice for drugs of abuse screening.

As the prevalence of designer drugs and new variations of drugs enter the market, workplace drug testing is set to increase in a bid to detect and deter use.

Corporations considering Workplace Drug Testing should seek to implement a drug policy and screening program in accordance with their National guidelines.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rapid Diagnosis of Myocardial Infarction within Six Hours
Randox develops a multi marker Cardiac biochip array for rapid diagnosis of myocardial infarction and identification of at risk acute coronary syndrome patients.
Wednesday, April 08, 2009
Scientific News
Diagnostic Thread - Weaving the Future?
Researchers have created diagnostic threads that could pave the way for next-gen implantable and wearable diagnostics.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Adipose Analysis on Microfluidic Chips
Scientists have developed a microfluidic chip the works with minute liquid quantities to grow and study cells.
New Device can Study Electric Field Cancer Therapy
Microfluidic device allows study of electric field cancer therapy through low-intensity fields, preventing malignant cells spreading.
DNA Production Facility Begins Operation
Scientists mark the opening of the UK's first fully automated DNA construction and modification facility.
A “Micro Winery” That Makes Wine Continuously
An American professor, working in collaboration with EPFL, is developing a miniature device for producing wine non-stop and testing different fermentation processes.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
Tough New Hydrogel Hybrid Doesn’t Dry Out
Water-based material could be used to make artificial skin, longer-lasting contact lenses.
Lasers Carve the Path to Tissue Engineering
A new technique, developed at EPFL, combines microfluidics and lasers to guide cells in 3D space, overcoming major limitations to tissue engineering.
A Future Tool for Medicine, Food Safety
A new type of electronic sensor that might be used to quickly detect and classify bacteria for medical diagnostics and food safety has passed a key hurdle by distinguishing between dead and living bacteria cells.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!